Current evidence on prevention and management of contrast-induced nephropathy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613
Hou SH, Bushinsky DA, Wish JB et al (1983) Hospital acquired renal insufficiency: a prospective study. Am J Med 74:243–248
Thomsen HS, Almèn T, Morcos SK; Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600–2605
Sam AD 2nd, Morasch MD, Collins J et al (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313–318
Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14:1654–1656
Akgun H, Gonlusen G, Cartwright J et al (2006) Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med 130:1354–1357
Thomsen HS (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16:2619–2621
Marckmann P, Skov L, Rossen K et al (2006) Nephrogenic systemic fibrosis: suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17:2359–2362
Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178
Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254–261
Bettmann MA (2005) Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 20[Suppl 1]: i12–i17
Solomon R, DuMouchel W (2006) Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol 41:651–660
Aspelin P, Aubry P, Fransson S-G et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499
Kolehmainen H, Soiva M (2003) Comparison of Xenetix 300 and Visipaque 320 in patients with renal failure. Eur Radiol 13:B32–33
Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821
Thomsen HS, Morcos SK, Erley C et al (2008) Comparison of Iomeprol 400 and Iodixanol 320 in patients with chronic kidney disease undergoing abdominal computed tomography: the ACTIVE trial. Invest Radiol (in press)
Carraro M, Malalan F, Antonione R et al (1998) Effects of a dimeric vs. a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 8:144–147
Sharma SK, Kini A (2005) Effect of non-ionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 65:386–393
Tepel M, van der Giet M, Schwartzfeld C et al (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184
Hoffmann U, Fischereder M, Kruger B et al (2004) The value of Nacetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407–410
Thomsen HS (2006) Reducing the risk of contrast media induced nephrotoxicity. In: Thomsen HS (ed) Contrast media: safety issues and ESUR guidelines. Springer, Heidelberg, pp 35–46
Solomon R, Werner C, Mann D et al (1993) Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420
Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413–415
Dussol B, Morange S, Loundoun A et al (2006) A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 21:2120–2126
Bader BD, Berger ED, Heede MB, et al (2004) What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62:1–7
Krasuski RA, Beard BM, Geoghagan JD et al (2003) Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol 15:699–702
Trivedi HS, Moore H, Nasr S et al (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:c29–c34
Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336
Taylor AJ, Hotchkiss D, Morse RW, McCabe J (1998) PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114:1570–1574
Merten GJ, Burgess WP, Gray LV et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized trial. JAMA 291:2328–2338
Thomsen HS, Morcos SK (2006) Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 16:1835–1840
Finn WF (2006) The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 21[Suppl 1]:i2–i10
Thomsen HS, Morcos SK; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) In which patients should serum creatinine be measured before contrast medium administration? Eur Radiol 15:749–754
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41